Acadia Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operating Overview
Go back to Acadia Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operating Overview| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 27.01 -0.44 (1.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.45 | 52 Week High | $42.49 | |||
| Open | $27.37 | 52 Week Low | $16.64 | |||
| Day High | $27.48 | P/E | N/A | |||
| Day Low | $26.89 | EPS | $-0.42 | |||
| Volume | 856,737 | |||||
